share_log

先聲藥業:自願公告 - SIM0500(人源化GPRC5D-BCMA-CD3三特異性抗體)新藥臨床試驗申請獲美國食品藥品監督管理局批准

SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE INVESTIGATIONAL NEW DRUG FOR SIM0500 (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ISSUED BY U.S. FOOD AND DRUG ADMINISTRATION

香港交易所 ·  Mar 10 06:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more